Photo 238995656 © Zerbor |
Infectious Disease

How to measure improvement in Long COVID identified in an international consensus study

Dec. 4, 2023
Researchers say this will accelerate the understanding of, and the development of treatments for, Long COVID with major global impacts.
Photo 69490120 © Alexey Litvinenko |
Infectious Disease

CDC and FDA expedite the availability of additional doses of new RSV immunization for infants

Nov. 17, 2023
CDC and FDA will continue to be in close contact with manufacturers to ensure the availability of additional doses through end of this year and for early 2024 to meet the demand...
Photo 170999814 © Romolo Tavani |
Photo 178605247 © Yobro10 |
Illustration 214391882 © Doersbd21 |
Infectious Disease

Global platform study presents results to guide care of severely ill patients with COVID-19 using routinely available drugs

Nov. 2, 2023
A total of 290 U.S. patients participated in the vitamin C domain at UPMC, the Ohio State University Wexner Medical Center, and Oregon Health & Science University.
Photo 184685318 © Famveldman |
Dreamstime Xxl 184685318
Infectious Disease

Study reveals how young children’s immune systems tame SARS-CoV-2

Oct. 16, 2023
NIH-supported research finds key differences between children & adults with COVID-19.
Photo 201515145 © Rido |
Dreamstime Xxl 201515145
Infectious Disease

HHS and Pfizer reach agreement to increase patient access to Paxlovid

Oct. 16, 2023
HHS and Pfizer will begin preparations for Pfizer to transition Paxlovid to the commercial market in November 2023.
Photo 211084274 © MaddieRedPhotography |
Dreamstime Xxl 211084274
Infectious Disease

New funding to ensure 370 million children receive polio vaccinations and to boost health innovation in low-income countries

Oct. 11, 2023
Today, wild poliovirus remains endemic in just two countries – Pakistan and Afghanistan – and 80% of variant poliovirus cases are found in just four subnational regions.
Photo 211264193 © Skypixel |
Dreamstime Xxl 211264193
Infectious Disease

Vulnerability to different COVID-19 mutations depends on previous infections and vaccination, study suggests

Oct. 10, 2023
A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure.
Photo 213594764 © Andrey Popov |
Dreamstime Xxl 213594764
Infectious Disease

FDA authorizes updated Novavax COVID-19 vaccine

Oct. 4, 2023
Formulated to better protect against currently circulating variants.
Photo 148741014 © Vetre Antanaviciute-meskauskiene |
Dreamstime Xxl 148741014